15.12BMarket Cap
35.15P/E TTM
Key Figures
249.710Open
252.460High
508.88KVolume
35.15P/E TTM
18.10P/E Dynamic
--Dividend TTM
0.82%Turnover Ratio
251.070Prev. Close
243.300Low
95.73MTurnover
LossP/E Static
-78.22P/B
0.00%Div Yield TTM
32.36%ROA
250.74052wk High
1.10Volume Ratio
-378.08MNet Profit
61.98MShares
6.9400EPS TTM
0.41Beta
332.65%ROE
158.16052wk Low
3.65%Amplitude
92.90%Gross Margin
15.12BMarket Cap
-3.54Reward/Risk
2.41%Risk Rate
Currency: USD Updated: 2026-07-31 Key Insights
Ascendis Pharma A/S's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 11 out of 385 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Strong Buy, with the highest price target at 310.42.In the medium term, the stock price is expected to remain stable.Despite a weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Ascendis Pharma A/S's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Ascendis Pharma A/S Highlights
StrengthsRisks
Ascendis Pharma A/S News
More news coming soon, stay tuned...
Earnings Forecast
Strong Buy
Buy
Hold
Sell
Strong Sell
Ionis Pharmaceuticals Inc
IONS
25
Indicators
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Ascendis Pharma A/S Info
Ascendis Pharma A/S is a Denmark-based company that manufactures pharmaceutical products. The Company produces products for the treatments of growth hormone deficiency, endocrinology, central nervous system disorders, infectious diseases, and diabetes. The Company operates globally though its subsidiaries: Ascendis Pharma GmbH (Germany), Ascendis Pharma, Inc. (Delaware, United States), Ascendis Pharma Endocrinology, Inc. (Delaware, United States), Ascendis Pharma, Ophthalmology Division A/S (Denmark), Ascendis Pharma, Endocrinology Division A/S (Denmark), Ascendis Pharma Bone Diseases A/S (Denmark), Ascendis Pharma Growth Disorders A/S (Denmark) and Ascendis Pharma Oncology Division A/S (Denmark).
Ticker SymbolASND
CompanyAscendis Pharma A/S
CEOMoller Mikkelsen (Jan)
Websitehttps://ascendispharma.dk/
Shareholders
FAQs
What is the current price of Ascendis Pharma A/S (ASND)?
The current price of Ascendis Pharma A/S (ASND) is 243.81.
What is the symbol of Ascendis Pharma A/S?
The ticker symbol of Ascendis Pharma A/S is ASND.
What is the 52-week high of Ascendis Pharma A/S?
The 52-week high of Ascendis Pharma A/S is 250.74.
What is the 52-week low of Ascendis Pharma A/S?
The 52-week low of Ascendis Pharma A/S is 158.16.
What is the market capitalization of Ascendis Pharma A/S?
The market capitalization of Ascendis Pharma A/S is 15.11B.
Is Ascendis Pharma A/S (ASND) currently rated as Buy, Hold, or Sell?
According to analysts, Ascendis Pharma A/S (ASND) has an overall rating of STRONG BUY, with a price target of 310.42.
What is the Earnings Per Share (EPS TTM) of Ascendis Pharma A/S (ASND)?
The Earnings Per Share (EPS TTM) of Ascendis Pharma A/S (ASND) is -4.42.
